[1]
T. H. T. Thach et al., “EVALUATION OF TREATMENT OUTCOMES AND ASSOCIATED FACTORS IN RECURRENT AND METASTATIC EPITHELIAL OVARIAN CANCER WITH CHEMOTHERAPY COMBINED WITH BEVACIZUMAB AT CAN THO ONCOLOGY HOSPITAL IN 2023 - 2025”, CTJUMP, no. 91, pp. 30–37, Sep. 2025.